Description of the medicine: Solizymum (Solizymum)
Enzymatic (lipolytic) preparation obtained from the culture of Recnicillium solitum.
The porous mass or powder is light brown in color with a slight specific odor. Slightly soluble in water.
Solisim is a lipolytic enzyme. Hydrolyzes vegetable and animal fats; promotes the digestion and absorption of fats. The activity of the drug is determined by the ability to hydrolyze the emulsion of olive oil and expressed in LE (lipolytic unit).
Used for chronic pancreatitis with reduced lipolytic activity, for chronic diseases of the gastrointestinal tract (achilia, gastritis, hepatitis, cholecystitis, etc.).
It is taken orally during or immediately after a meal of 40,000 LE 3 times a day. The course of treatment is 3 to 4 weeks.
Release form: tablets of solisim (coated yellow) with a content of 20 000 LU, soluble in the intestine (Tablettae Solizymi 20 000 LU enterosolubiles), in a package of 100 pieces.
Storage: in a dry, dark place at a temperature of no higher than + 4 'C.